Brought to you by 
PIPE brings in $900mm for Shire
21 Feb 2007
Executive Summary
To partially fund its recently announced acquisition of New River Pharmaceuticals for $2.6bn, Shire PLC has grossed $900mm (£461mm) through a private placement of about 42.88mm new ordinary shares at $20.98 each (market average) to institutional investors.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
PIPE brings in $900mm for Shire
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice